Corporate Profile: Novartis

Novartis Group Companies are steeped in tradition. We are constantly evolving to meet the demands of today's marketplace. By building on the past of our predecessor companies -- CIBA - Geigy - Sandoz -- and capitalizing on today's cutting-edge technologies, Novartis, is moving to the forefront of the pharmaceutical industry. Novartis - which comes from the Latin novae artes for "new skills" - means utilizing scientific research, imagination, and new technologies to provide ever-greater benefits for humankind.

Tuesday, March 7, 2000

Visitors: Executive MBA Fellows of the Rockhurst University, Kansas City, USA

8:30 a.m. Arrival at Novartis St. Johann, Gate 10, Hüningerstrasse, Basel

A member of the VIP Service will meet our guests at the gate

Auditorium 510

8:40 a.m. Coffee break in the foyer

9:00 a.m. Welcome address and introduction to Novartis

9:20 a.m. Novartis – Full Year Results and Business Outlook

by Dr. Karen Huebscher, Investor Relations Manager, Novartis International AG

9:45 a.m. "Consolidation in the Pharmaceutical Industry" by Dr. Ernst Buser, Head of Economic Affairs/International Relations, Novartis International AG

10:10 a.m. "Knowledge Networking at Novartis" by Dr. Joerg Staeheli, Senior Officer of Corporate Knowledge Management, Novartis International AG

10:35 a.m. Q & A session

11:15 a.m. Split up into three groups for factory tour

12:00 p.m. Lunch at the Novartis Visitor’s Restaurant 501 on the 5^th floor with all participants.

13:30 p.m. End of visit and departure